home All News open_in_new Full Article

Rovi sube en bolsa después de que su competido Sanofi se desplome un 9%

Las acciones de Laboratorios Rovi continúan al alza y se disparan este jueves en torno al 5% después de que su competidor Sanofi se desplomara en torno al 9 % en el Euro Stoxx50. Los títulos de Rovi son los que más suben del IBEX 35, un 4,56 %, y se sitúan en 60,8 euros. […] The post Rovi sube en bolsa después de que su competido Sanofi se desplome un 9% appeared first on Radio Intereconomía.


today 8 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Society
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events


ID: 228292831
Add Watch Country

arrow_drop_down